Qingsong Health Group (2661.HK), a newly listed entity on the Hong Kong Stock Exchange, initiated grey market trading on December 22nd. Upon the market's opening, its share price witnessed a robust surge. By the close of the grey market session, the share price had escalated by over 110% from its issue price, propelling the market capitalization to approach 10 billion. Prior to this, the global offering of this stock had seen an overwhelming subscription, with demand exceeding supply by 1,421 times. The grey market's significant opening premium underscored the capital market's confidence in Qingsong Health's 'AI + Full-Chain Digital Health' model.

As a premier integrated digital health platform in China, Qingsong Health commands a vast user base. Leveraging AI technology, the company continuously refines its business structure to empower its operations. On December 23rd, Qingsong Health is set to officially list on the main board of the Hong Kong Stock Exchange. The proceeds from the offering will be earmarked for AI technology enhancements and other strategic initiatives. Industry experts anticipate that, following its listing, Qingsong Health will garner significant capital attention, offering investors promising long-term returns.